Gallium dotatate ga-68

From WikiMD's WELLNESSPEDIA

Gallium Dotatate Ga-68 is a type of radiopharmaceutical used in Positron Emission Tomography (PET) scans. It is a compound that combines the element gallium with a substance called DOTATATE, which binds to certain types of tumors. The gallium is made radioactive (Ga-68) so it can be detected by the PET scanner.

History[edit]

Gallium Dotatate Ga-68 was approved by the Food and Drug Administration (FDA) in the United States in 2016. It was developed as a diagnostic tool for neuroendocrine tumors, which are difficult to detect using traditional imaging methods.

Usage[edit]

Gallium Dotatate Ga-68 is used in PET scans to help detect and locate neuroendocrine tumors. The DOTATATE in the compound binds to somatostatin receptors, which are found in high numbers on these types of tumors. The radioactive gallium allows these tumors to be seen on the PET scan.

Procedure[edit]

The Gallium Dotatate Ga-68 is injected into the patient's bloodstream. It travels through the body and binds to the somatostatin receptors on the neuroendocrine tumors. The patient is then scanned with a PET scanner, which can detect the radiation from the gallium and create images of the tumors.

Risks and Side Effects[edit]

As with any medical procedure, there are potential risks and side effects associated with the use of Gallium Dotatate Ga-68. These may include allergic reactions, kidney damage, and radiation exposure. However, the benefits of accurately diagnosing neuroendocrine tumors often outweigh these risks.

See Also[edit]

Diagnostic radiopharmaceuticals (V09)
Central nervous system
Skeletal system
Renal
Gastrointestinal/Hepatic
Respiratory system
Isotopes used:
See also: Therapeutic radiopharmaceuticals (V10)


Medical imaging
X-ray/
radiography
MRI
Ultrasound
Radionuclide
Optical/Laser




Oncology
Basics
Diagnostics
Treatments
Types of Cancers
Related Fields
This oncology-related article is a stub.



Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Gallium_dotatate_ga-68&oldid=5345485"